Ocrelizumab: Short vs Standard Infusion Time in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ocrelizumab Shorter Infusion: Primary Results From the ENSEMBLE PLUS Substudy in Patients With MS
Neurol Neuroimmunol Neuroinflamm 2020 Sep 01;[EPub Ahead of Print], HP HartungFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.